daytrading may 24 afternoon, page-87

Here's what I wrote on the per trading today still stand by it.


PXS PXS Risk/reward trading idea currant (18c)

With PXS trading at 18c yesterday (down from a 6mth high of $1.20 without

FDA approval) . Were will it be with FDA approval.


PXS now have clear directions from the FDA in their agreement with

"key cystic fibrosis trial parameters" the downside risk is imo is a 12c sp but

passing FDA approval will send this stock well north of $1 plus plus plus.

Underwritten by $73million cash in bank (31Mar2013). MC $55Mill ($18c)

Next Tues 28may conference call should add extra shareholder value.

I took a LT position yesterday and will endeavour to add today ;)